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Introduction 
Depression affects a large portion of the world’s population. It can develop at any age, 
and has a high risk of relapse if left untreated or undiagnosed. Depression is known to be caused 
by decreased serotonin levels and has been linked to other chemical and behavioral changes 
within the brain. The illness has historically been treated with treatments such as selective 
serotonin reuptake inhibitors (SSRIs) in moderate to severe cases, and electroconvulsive therapy 
in severe cases. Although these treatments have shown limited rates of success, each method has 
its disadvantages. SSRIs cannot totally relieve symptoms, and patients incur the risk of relapse. 
Side effects such as diarrhea, headaches, sleep disorders, and nausea may occur with the 
administration of SSRIs. On the other hand, ECT is only available to a select portion of the 
population that has severe depression, and if not administered correctly, could result in severe 
brain damage. To make treatments more effective, it is more necessary to understand the 
biochemical pathways through which depression manifests itself specifically on a biological 
basis.  
The dentate gyrus is a small area within the hippocampus of the brain that contains a 
niche of adult neural stem cells. It is responsible for regulating and maintaining memory, 
learning, mood, pattern separation, and reward processing. Therefore, the disruption of ANSC 
function could heavily impact any of the processes linked with the dentate gyrus. The basis of 
many mental illnesses lies in the dysregulation of many mental functions, including those that 
the dentate gyrus is responsible for. The neurogenesis hypothesis of depression states that 
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decreased neurogenesis increases an individual’s vulnerability or susceptibility to depression. 
Meanwhile, an increase in neurogenesis has the opposite effect: increased neurogenesis increases 
the ability for pattern separation and cognitive flexibility. Common treatments for depression, 
like SSRIs and ECT, cause an increase in neurogenesis and proliferation of neurons in mice. 
These treatments can cause stem cells to mature at a higher rate and give them a higher rate of 
survival in the adult brain. Many therapeutics for depression attempt to increase the amount of 
the neurotransmitter serotonin, a lack of which characterizes the disorder. This connection 
between neurogenesis and depression treatment drives us to explore the pathways that mediate 
serotonin’s effect on neurogenesis further to elucidate more efficient treatment methods.   
Neurogenesis occurs in the subgranular zone (SGZ) of the dentate gyrus, just below the 
granule cell layer, which is a concentrated band of neuron soma. The pool of adult neural stem 
cells (ANSCs) can go through three potential pathways: self-renewal, gliogenesis, or 
neurogenesis.  The first pathway of self-renewal replenishes the pool of neural stem cells, which 
can be either activated or quiescent. When in an active state, neural stem cells can differentiate 
into astrocytes or neurons. The neurogenesis pathway involves a neural stem cell (Type 1 cell) 
differentiating into a progenitor cell (Type 2 cell), which goes through mass replication and 
creates several neuroblasts (Type 3 cells). These later differentiate into granule cell neurons. A 
large percentage of these newly-formed neurons die due to their inability to make useful synaptic 
integrations, and the remaining cells integrate into neural circuits by forming synapses and 
connecting to other, already established neurons.   
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Figure 1. This diagram explains the neurogenesis pathway, where quiescent, or inactive, 
stem cells in the SGZ differentiate into neurons in the molecular layer of the dentate gyrus. 
 
A hallmark of adult neurogenesis is its regulation by the activity in the brain. Many 
neurotransmitters, such as serotonin, regulate neurogenesis in the dentate gyrus. Serotonin inputs 
from the Median Raphe project to the hippocampus, including innervation of the SGZ, and affect 
anxiety behavior. However, it is unclear how serotonin inputs may be specifically regulating the 
multi-step process of neurogenesis. Granule cell neurons (including adult neural stem cells) are 
known to express two different receptors for serotonin, the 5HT-1a receptor and the 5HT-4 
receptor. Firstly, we set out to ask if the precursors of neurons express these receptors, and if so, 
at what stage. Secondly, we took a functional genetic approach of conditionally deleting Htr1a 
(gene encoding for 1a) using CreER drivers specifically in adult neural stem cells and using 
immunohistochemistry to determine how stem cells react to loss of Htr1a. 
Additionally, we set out to discern whether the administration of SSRIs (selective 
serotonin reuptake inhibitors), a class of antidepressants, would affect rates of neurogenesis in 
mice. Previous evidence suggests that they can be administered to increase neurogenesis, 
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especially in animals that have diminished levels of ANSC activity (Malberg, Eisch, Nestler, & 
Duman, 2000). Specifically, we will be examining the effects of the SSRI fluoxetine and its 
effect on the change of the rate of neurogenesis of ANSCs. After confirming that fluoxetine 
causes an increase in the proliferation of adult neural stem cells, we will later conditionally 
delete the 5ht1a gene in mice to investigate if the 5HT1A receptor is relevant to the pathway that 
allows fluoxetine to mediate an increase in neurogenesis.  
Methods: 
Immunohistochemistry 
Mice were taken at 7 days post-injection, transcardially perfused with PBS, and then a 4% PFA 
solution. After 24 hours, brains were switched into 30% sucrose in PBS solution. After 48 hours, 
brains were coronally sectioned on a microtome at 40 µm. Primary antibodies were stained on 
free-floating sections in PBS (GFP 1:1000, GFAP 1:1000, DCX 1:1000, SOX2 1:1000, EdU 
1:300). Secondary antibody was also applied on free floating sections. Sections were then 
mounted on glass slides and imaged through an epifluorescent microscope.  
In-Situ Hybridization(ISH) 
Samples were sectioned and mounted onto slide. Humidifying paper is doused with water and 
placed in the hybridization oven is heated up to 40°C. Slide were applied with Pretreat solution 
1, then boiled in a second pretreat solution for 5 minutes. Slides were washed in distilled water 
and 100% ethanol, then let dry. A hydrophobic barrier was made on the slide, which then had the 
third pretreatment solution applied to it. The slides are incubated in the HybEZ Humidifying 
Oven for 30 min, then washed in distilled water.  
Probe is added to the slides, then placed in the oven for 2 hours. Amplification rounds, as well as 
a fluorescent probe, are added and incubated. Sections are counterstained and then mounted. 
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Administration of SSRIs (Fluoxetine)  
Fluoxetine was administered at a concentration of 200 mg/kg dissolved in saline solution, 
administered in the form of an intraperitoneal injection. Fluoxetine was administered daily in 200 
µL doses for a period of 14 days. An EdU solution of 14 mg/mL was administered 
intraperitoneally on the 14th day, and the animals were perfused 2 hours after the EdU injection.    
Results: 
5-HT-1a expression studies 
Previous studies indicate that the 5HT-1a receptor is expressed highly in dentate granule 
cell neurons. However, the expression of the 5HT-1a receptor in stem cells is unclear. Therefore, 
our first set of experiments investigated the 5HT-1a receptor’s expression in ANSCs, which 
initiate neurogenesis. To see if 5HT-1a was directly expressed in stem cells, we performed an in 
situ hybridization (ISH) assay (Figure 4). Cells that were positive for the 5HT-1a mRNA 
sequences were very clearly visible throughout the brain. Expression of the 5HT-1a receptor in 
the dentate gyrus was robust, with many positive cells in the SGZ. To identify co-expression of 
the 1a probe in stem cells, we performed dual immunohistochemistry and ISH.  
We stained for GFP in Nestin-GFP mice that are genetically modified to express GFP 
only in stem cells. We additionally obtained a second line of Aspm-GFP reporter mice that 
would express GFP selectively in progenitor cells. After increasing magnification, we observed 
1a probe localization on the cell membranes of GFP labeled stem and progenitor cells, providing 
visual evidence that the mRNA for the 5HT1A receptor was available for transcription near the 
membrane of ANSCs and progenitor cells.  
Conditional labeling of stem cells in vivo 
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Our next goal of the project was to delete the 5HT-1a receptor specifically from stem 
cells in living mice and to use immunohistochemistry to see if there was a change in phenotype 
from receptor loss during neurogenesis. To confirm that we can target stem cells for Cre 
recombination, we performed genetic crossing of Nestin CreER mice with two reporter lines, 
Ai3 and MTMG. Ai3 is a GFP reporter, while MTMG is an RFP/GFP switch that is membrane 
tagged.  
CreER is a technology that uses a modified estrogen receptor which has a high affinity 
for tamoxifen to perform inducible Cre activation. By using a Nestin CreER line we can express 
CreER only in stem cells and then activate Cre via intraperitoneal injection of tamoxifen. In 
combination with the Ai3 line, the CreER recombines with the double floxed stop codon 
upstream of the GFP gene that initiates ubiquitous transcription and therefore continual 
translation of GFP. Cell morphology and fluorescence is then observed under an epifluorescent 
microscope. 
We initially set up an experiment comparing tamoxifen concentration to the amount of 
cells that were labeled in Nestin CreER; Ai3+ mice. Several control samples from the colony 
were taken, intraperitoneally injected with tamoxifen or corn oil as a control, and then perfused. 
Sections from these mice were labeled with DAPI and GFP, then imaged by the epifluorescent 
microscope. Imaging showed high expression of GFP not exclusive to adult neural stem cells. 
We observed an excessive amount of GFP labeled neurons (Figure 2). GFP cells were present 
with a low (.0001 g/microliter) dosage of tamoxifen and surprisingly observed by negative, no 
tamoxifen control animals. The spontaneous recombination led to nonspecific labeling of cells in 
the dentate gyrus and inaccurate observation of our cells of interest.  
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Figure 2.  The DG of Ai3; NesCreER shows excessive GFP labeling due to spontaneous 
recombination.  
  To achieve better results, we switched from a Nestin CreER line to one with the MTMG-
reporter line. This line initially expresses mtdTomato, but cells that have been successfully 
recombined lose mtdTomato expression but gain mGFP expression after tamoxifen induction. 
The line showed little to no spontaneous recombination and therefore effectively allowed us to 
label stem cells. A composite image of the three stains displays GFP+ Type I cells to be located 
in the subgranular zone, just below the Prox1+ granule cell layer.  
Conditional deletion of 5HT-1a in stem cells in vivo 
Mice with our engineered cross of Nestin CreER; MTMG were bred into an Htr1a floxed 
line to obtain Nestin CreER; MTMG; Htr1a fl/+ (1a heterozygous) and Nestin CreER; MTMG; 
Htr1a fl/fl (1a homozygous). A conditional knockout involves two alleles of the double floxed 
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htr1a, while the heterozygous mouse only has one allele of the double floxed htr1a and one wild 
type allele. With this combination of genotypes we are able to track when and in what cells the 
Htr1a gene has effectively been spliced out of the genome by the Cre recombinase. 
 
Figure 3.  (A) Prox1 stain of the dentate gyrus. (B) A GFP-expressing Type I stem cell 
found in the DG. (C) an anti-mTdtomato stain of the DG. (D) A composite image of A, B, 
and C, illustrating the position of Type I cells. (E) The phenotype of a conditional knockout 
mouse. (F) The phenotype of a heterozygous floxed animal. (G) AntiGFP-stained neurons 
in the conditional knockout mouse.   
We injected a single dose of tamoxifen to 1a heterozygous and 1A homozygous mice. 
We then waited 7 days after injection before perfusion to allow time for stem cell development. 
After sectioning, staining and imaging both genotypes, we observed that tagged cells included 
Type I cells, as well as Type I cells that had differentiated into progeny cell types. These cell 
types were especially highlighted when we investigated the difference between 1a heterozygous 
and 1a homozygous mice. From our data, we observed that the heterozygote mice have more 
GFP-labeled stem cells that have differentiated into astrocytes while cKO (conditional knockout) 
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mice have more stem cells that have differentiated into neurons. Astrocytes are characterized as 
round cells with several projections. Neurons are characterized as having a small cell body with 
few, thin processes projecting outwards (Figure 3).  
 
Figure 4. (A) In situ hybridization probes attached to 5ht1a mRNA. (B) The dentate gyrus 
tagged with 5HT-1a probe. (C) GFP labeled stem cells in the SGZ with the 5HT-1a probe. 
(D) GFP-labeled stem cells and 5HT-1a probe along the SGZ. 
In Vivo Lineage Tracing of ANSCs: 
We next set out to ask how rates of ANSC proliferation and differentiation varied in the 
presence of the 5HT1A receptor. After administering tamoxifen to the mice and inducing 
consequent 5htr1a deletion, we obtained samples from which we could image ANSCs and their 
progenitor cells. Using antibodies specific to each cell type, we then tracked the proliferation, 
migration, and differentiation of Type I, Type II, and Type III cells within the dentate gyri of 
wild type, 5htr1a heterozygous knockout, and 5htr1a homozygous knockout mice (Figure 5).  
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Figure 5. (A) The dentate gyrus of a homozygous knockout mouse taken 8 days after 
injection. (B) A magnified portion of the dentate gyrus, showing the several types of 
fluorescent tags used to identify various cell types. (C) The dentate gyrus stained with 
tdTomato, a common marker for Type III cells. (D) The same portion of the dentate gyrus 
stained with SOX2 and GFAP, two protein markers indicative of Type I cells. (E) Some 
cells expressed Ki67, a marker of Type II cells and active cell proliferation.  
After analyzing several images of dentate gyri and performing double-blind manual cell 
counting of each cell type across several specimens, we found that the presence or absence of the 
5HT1A receptor in ANSCs and progenitor cells did not change rates of proliferation or 
differentiation within the dentate gyrus (Figure 6). There was no statistically significant 
difference in the relative abundance of proliferating or stem-like cells across the three genotypes 
previously mentioned. This implies that at a baseline level, meaning in the absence of stress or 
chemical imbalance, there is no immediate proliferative or differentiative consequence in 
association with the absence of the 5HT1A receptor.  
B
c
v 
B
c
v 
A
v 
C
v 
D
v 
E
v 
 11 
 
Figure 6. (A) Normalized cell counts of Type I, Type II, and Type III cells of the three 
5ht1ar genotypes (n=8 per genotype). (B) Compiled relative percentages of Type I, Type II, 
and Type III cells across the dentate gyri of the 3 genotypes.  
Effect of SSRIs on Neurogenesis: 
Using the same Cre-lox technology described above, we induced the deletion of the 5ht1a 
receptor gene in both homozygous and heterozygous constructs while providing half of our 
population consistent fluoxetine treatment over 14 days, with the other half receiving PBS for the 
same period of time as a control. From a preliminary pilot study, we found that the density of 
Ki67+ cells within the dentate gyrus was significantly higher in the tissue of the mice receiving 
fluoxetine treatment in comparison to the control. This confirms our previous hypothesis that 
fluoxetine acts to increase proliferation within the dentate gyrus at a baseline level (Figure 7B-
C). After taking a larger set of samples (n=40), we began to compile data on the relative 
abundance of each cell type relative to genotype and fluoxetine administration. Though there was 
no marked difference in the total number of cells in the dentate gyrus across all four conditions, 
the heterozygous mice showed a decrease in both proliferating and stem-like cells upon the 
administration of fluoxetine (Fig. 7D-F). This implies that fluoxetine works through a pathway 
involving the 1a receptor to push for these two cell types to mature into neuroblasts and neurons. 
We additionally observed a decrease in relative abundance of Type I and an increase in relative 
A 
B 
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abundance of Type III cells between the heterozygous and homozygous knockout control 
samples7 (Fig. 7G). This data provides evidence for the mediation of lineage progression and 
increased stem cell maturation by fluoxetine through a 5HT1A receptor-mediated pathway.   
 
 
 
Figure 7. (A) Experimental timeline of fluoxetine, tamoxifen, and fixative administration 
for specimens. (B) Ki67 expression increases in the dentate gyrus of mice receiving 
fluoxetine versus the control PBS treatment. (C) Quantified differential values of Ki67+ 
cells in treatment versus control pilot experiment (n=2). (D-F) Normalized cell counts of all 
cells (D), proliferating cells (E), and stem-like cells (F) present in the dentate gyrus in 
knockout and heterozygous mice receiving the treatment and control (n=10 per genotype).  
(G) Relative percentages of Type I, Type II, and Type III cells in dentate gyri of 
homozygous and heterozygous knockout mice that were administered fluoxetine or PBS. 
Discussion: 
 
A 
D 
B 
E
 
G 
F 
C 
 13 
The 1a sequence is found in neurons throughout the hippocampus and it is known that the 
5HT-1a receptor acts in some capacity to modulate cellular response upon detection of serotonin 
inputs. In our ISH experiments, we observed that 5htr1a mRNA sequences were found in close 
proximity to adult neural stem cells. This is the first non-sequencing evidence that we are aware 
of that profiles stem cells as 1a+, although expression of the receptor and its mRNA was much 
less than that expressed in neurons.  
In support of 1a expression in stem cells, we observed that conditional deletion of htr1a 
affects stem cells differently in mice who are conditional knockouts versus heterozygotes. 
Heterozygotes have more tagged cells that have differentiated into astrocytes, meaning that more 
tagged cells have gone through gliogenesis. Conditional knockouts have labeled more neurons 
with GFP, meaning that more labeled neurons have gone through neurogenesis. This indicates 
that the 5HT1A receptor may play a role in deciding the fate of ANSC daughter cells, as well as 
committing a particular ANSC into differentiation into glia or neurons.  
We later obtained more samples from conditional knockouts and heterozygotes in order 
to qualitatively assess the difference between differentiation of stem cells in both genotypes in 
response to the administration of SSRIs. After replicating our pilot experiment, we were able to 
confirm that fluoxetine increases proliferation in the dentate gyrus. In studying the effects of 
fluoxetine administration on adult neurogenesis, we have shed light on the biochemical pathway 
that mediates this specific method of depression treatment.  
 Although our experiments show that 1a does not mediate neurogenesis at a baseline 
level, we do have evidence to show that the receptor is involved in the increased rate of ANSC 
differentiation and maturation in a high-serotonin environment (induced by consistent fluoxetine 
administration). This leads us to ask whether 5htr1a mediates cellular response to other stressors 
 14 
or changes in chemical environment. Future experiments will focus on administering acute and 
chronic stress paradigms to mice and observing the effect of 5htr1a deletion on cell proliferation 
and differentiation within the dentate gyrus. Preliminary results show that stress causes a 
decrease in proliferation and available stem-like cells in the dentate gyrus. Our research has 
shown that the 5HT1A receptor plays an integral role in serotonergic regulation of adult 
neurogenesis when the organism is presented with aberrantly high levels of serotonin. Further 
investigation into the pathway through which the 5HT1A receptor mediates this intricate process 
could provide us with knowledge that can be applied to further increase the efficacy of current 
therapeutic treatments for depression.   
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